Skip to main content
TipRanks
Go Ultimate75% OFF

Vicore Pharma Holding AB Sponsored ADR (VCRE) Stock Statistics & Valuation Metrics

3 Followers

Total Valuation

Vicore Pharma Holding AB Sponsored ADR has a market cap or net worth of $284.42M. The enterprise value is $190.38M.

Market Cap
$284.42M
Enterprise Value
$190.38M

Share Statistics

Vicore Pharma Holding AB Sponsored ADR has 28,164,452 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
28,164,452
Owned by Insiders
―
Owned by Institutions
4.20%

Financial Efficiency

Vicore Pharma Holding AB Sponsored ADR’s return on equity (ROE) is -0.44 and return on invested capital (ROIC) is -41.31%.

Return on Equity (ROE)
-0.44
Return on Assets (ROA)
-0.39
Return on Invested Capital (ROIC)
-41.31%
Return on Capital Employed (ROCE)
-0.41
Revenue Per Employee
103.16K
Profits Per Employee
-12.90M
Employee Count
37
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Vicore Pharma Holding AB Sponsored ADR is -5.47. Vicore Pharma Holding AB Sponsored ADR’s PEG ratio is -0.35.

PE Ratio
-5.47
PS Ratio
756.35
PB Ratio
4.00
Price to FCF
-8.60
Price to Operating Cash Flow
-5.90
PEG Ratio
-0.35

Income Statement

In the last 12 months, Vicore Pharma Holding AB Sponsored ADR had revenue of 3.82M and earned -477.47M in profits. Earnings per share was -2.20.

Revenue
3.82M
Gross Profit
3.82M
Operating Income
-454.44M
Pretax Income
-477.47M
Net Income
-477.47M
EBITDA
-477.41M
Earnings Per Share (EPS)
-2.20

Cash Flow

In the last 12 months, operating cash flow was -352.67M and capital expenditures 0, giving a free cash flow of -352.67M billion.

Operating Cash Flow
-352.67M
Free Cash Flow
-352.67M
Free Cash Flow per Share
-11.92

Dividends & Yields

Vicore Pharma Holding AB Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-11.63%
Earnings Yield
-17.66%

Stock Price Statistics

Beta
0.55
52-Week Price Change
-26.47%
50-Day Moving Average
9.91
200-Day Moving Average
10.98
Relative Strength Index (RSI)
50.18
Average Volume (3m)
23.28K

Important Dates

Vicore Pharma Holding AB Sponsored ADR upcoming earnings date is Feb 25, 2027, Before Open (Not Confirmed).

Last Earnings Date
Nov 05, 2026
Next Earnings Date
Feb 25, 2027
Ex-Dividend Date
―

Financial Position

Vicore Pharma Holding AB Sponsored ADR as a current ratio of 10.28, with Debt / Equity ratio of 0.00%

Current Ratio
10.28
Quick Ratio
10.28
Debt to Market Cap
0.00
Net Debt to EBITDA
1.21
Interest Coverage Ratio
-7574.08

Taxes

In the past 12 months, Vicore Pharma Holding AB Sponsored ADR has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Vicore Pharma Holding AB Sponsored ADR EV to EBITDA ratio is -4.42, with an EV/FCF ratio of -7.43.

EV to Sales
652.93
EV to EBITDA
-4.42
EV to Free Cash Flow
-7.43
EV to Operating Cash Flow
-5.07

Balance Sheet

Vicore Pharma Holding AB Sponsored ADR has $771.99M in cash and marketable securities with $0.00 in debt, giving a net cash position of $771.99M billion.

Cash & Marketable Securities
$771.99M
Total Debt
$0.00
Net Cash
$771.99M
Net Cash Per Share
$27.41
Tangible Book Value Per Share
$25.68

Margins

Gross margin is 100.00%, with operating margin of -14161.60%, and net profit margin of -13397.10%.

Gross Margin
100.00%
Operating Margin
-14161.60%
Pretax Margin
-13390.33%
Net Profit Margin
-13397.10%
EBITDA Margin
-14756.35%
EBIT Margin
-14756.35%

Analyst Forecast

The average price target for Vicore Pharma Holding AB Sponsored ADR is $25.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$25.00
Price Target Upside
152.53% Upside
Analyst Consensus
Strong Buy
Analyst Count
3
Revenue Growth Forecast
-50.05%
EPS Growth Forecast
-9.20%

Scores

Smart Score
6
AI Score
―